The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Streptococcus pneumoniae

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Streptococcus pneumoniae

 

Psychiatry related information on Streptococcus pneumoniae

 

High impact information on Streptococcus pneumoniae

 

Chemical compound and disease context of Streptococcus pneumoniae

 

Biological context of Streptococcus pneumoniae

 

Anatomical context of Streptococcus pneumoniae

 

Gene context of Streptococcus pneumoniae

 

Analytical, diagnostic and therapeutic context of Streptococcus pneumoniae

References

  1. Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae. Lonks, J.R., Durkin, M.R., Meyerhoff, A.N., Medeiros, A.A. N. Engl. J. Med. (1995) [Pubmed]
  2. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Binder, C.J., Hörkkö, S., Dewan, A., Chang, M.K., Kieu, E.P., Goodyear, C.S., Shaw, P.X., Palinski, W., Witztum, J.L., Silverman, G.J. Nat. Med. (2003) [Pubmed]
  3. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. Plouffe, J.F., Breiman, R.F., Facklam, R.R. JAMA (1996) [Pubmed]
  4. Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Engelhard, D., Cohen, D., Strauss, N., Sacks, T.G., Jorczak-Sarni, L., Shapiro, M. Lancet (1989) [Pubmed]
  5. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Blackwell, C.C., Jónsdóttir, K., Hanson, M., Todd, W.T., Chaudhuri, A.K., Mathew, B., Brettle, R.P., Weir, D.M. Lancet (1986) [Pubmed]
  6. Delivery rates for preventive services in 44 midwestern clinics. Kottke, T.E., Solberg, L.I., Brekke, M.L., Cabrera, A., Marquez, M.A. Mayo Clin. Proc. (1997) [Pubmed]
  7. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Gilbert, R.J., Jiménez, J.L., Chen, S., Tickle, I.J., Rossjohn, J., Parker, M., Andrew, P.W., Saibil, H.R. Cell (1999) [Pubmed]
  8. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. Chen, D.K., McGeer, A., de Azavedo, J.C., Low, D.E. N. Engl. J. Med. (1999) [Pubmed]
  9. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P.F., Martin, R., Gudiol, F. N. Engl. J. Med. (1995) [Pubmed]
  10. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Cundell, D.R., Gerard, N.P., Gerard, C., Idanpaan-Heikkila, I., Tuomanen, E.I. Nature (1995) [Pubmed]
  11. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. McNamara, M.K., Ward, R.E., Kohler, H. Science (1984) [Pubmed]
  12. Effect of high-dose amoxicillin on the prevalence of penicillin-resistant Streptococcus pneumoniae in rural Alaska. Hennessy, T.W., Bruden, D., Petersen, K.M., Parkinson, A.J., Hurlburt, D., Getty, M., Butler, J.C., Schwartz, B. JAMA (2002) [Pubmed]
  13. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Dillard, J.P., Vandersea, M.W., Yother, J. J. Exp. Med. (1995) [Pubmed]
  14. Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis. Mollerach, M., López, R., García, E. J. Exp. Med. (1998) [Pubmed]
  15. Low frequency of erythromycin-resistant Streptococcus pneumoniae in The Netherlands. Endtz, H.P., Peetermans, W.E., Bijlmer, H.A. Lancet (1989) [Pubmed]
  16. Letter: Bacteraemia caused by tetracycline-resistant Pneumococcus type 1. Bullen, B., Hansman, D. Lancet (1975) [Pubmed]
  17. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Navarre, W.W., Schneewind, O. Microbiol. Mol. Biol. Rev. (1999) [Pubmed]
  18. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. Bjornson, A.B., Lobel, J.S. J. Clin. Invest. (1987) [Pubmed]
  19. Staphylococcal plasmids that replicate and express erythromycin resistance in both Streptococcus pneumoniae and Escherichia coli. Barany, F., Boeke, J.D., Tomasz, A. Proc. Natl. Acad. Sci. U.S.A. (1982) [Pubmed]
  20. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. Claflin, J.L., Berry, J. J. Immunol. (1988) [Pubmed]
  21. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. Kuronuma, K., Sano, H., Kato, K., Kudo, K., Hyakushima, N., Yokota, S., Takahashi, H., Fujii, N., Suzuki, H., Kodama, T., Abe, S., Kuroki, Y. J. Biol. Chem. (2004) [Pubmed]
  22. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. Mold, C., Nakayama, S., Holzer, T.J., Gewurz, H., Du Clos, T.W. J. Exp. Med. (1981) [Pubmed]
  23. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. Colino, J., Shen, Y., Snapper, C.M. J. Exp. Med. (2002) [Pubmed]
  24. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. Janoff, E.N., Fasching, C., Orenstein, J.M., Rubins, J.B., Opstad, N.L., Dalmasso, A.P. J. Clin. Invest. (1999) [Pubmed]
  25. Effects of CD18 deficiency on the emigration of murine neutrophils during pneumonia. Mizgerd, J.P., Horwitz, B.H., Quillen, H.C., Scott, M.L., Doerschuk, C.M. J. Immunol. (1999) [Pubmed]
  26. Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. Papadopoulos, M.C., Verkman, A.S. J. Biol. Chem. (2005) [Pubmed]
  27. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Haas, K.M., Hasegawa, M., Steeber, D.A., Poe, J.C., Zabel, M.D., Bock, C.B., Karp, D.R., Briles, D.E., Weis, J.H., Tedder, T.F. Immunity (2002) [Pubmed]
  28. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. Clatworthy, M.R., Smith, K.G. J. Exp. Med. (2004) [Pubmed]
  29. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. Arredouani, M., Yang, Z., Ning, Y., Qin, G., Soininen, R., Tryggvason, K., Kobzik, L. J. Exp. Med. (2004) [Pubmed]
  30. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Rijneveld, A.W., Florquin, S., Bresser, P., Levi, M., De Waard, V., Lijnen, R., Van Der Zee, J.S., Speelman, P., Carmeliet, P., Van Der Poll, T. Blood (2003) [Pubmed]
  31. A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide. Agrawal, A., Simpson, M.J., Black, S., Carey, M.P., Samols, D. J. Immunol. (2002) [Pubmed]
  32. Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. Gennery, A.R., Cant, A.J., Spickett, G.P., Walshaw, D., Hunter, S., Hasan, A., Hamilton, J.R., Dark, J. Lancet (1998) [Pubmed]
  33. Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. Umemoto, J., Bhavanandan, V.P., Davidson, E.A. J. Biol. Chem. (1977) [Pubmed]
  34. Two distinct UDP-galactose: 2-acetamido-2-deoxy-D-glucose 4 beta-galactosyltransferases in porcine trachea. Sheares, B.T., Carlson, D.M. J. Biol. Chem. (1984) [Pubmed]
  35. New Real-Time PCR Assay Using Locked Nucleic Acid Probes To Assess Prevalence of ParC Mutations in Fluoroquinolone-Susceptible Streptococcus pneumoniae Isolates from France. Decousser, J.W., Methlouthi, I., Pina, P., Collignon, A., Allouch, P. Antimicrob. Agents Chemother. (2006) [Pubmed]
  36. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats. Iinuma, H., Okinaga, K. J. Infect. Dis. (1989) [Pubmed]
 
WikiGenes - Universities